Skip to content

4Accepted Sep 28, 4:31 PM ET

Imunon (IMNN) Exec Chairman Michael H. Tardugno Receives 7,169 Shares

IMNNImunon, Inc.

Accepted (ET)

4:31 PM

Sep 28, 2026

Filed

Sep 28, 2026

Documents

1

Size

5.6 KB

Summary

Imunon (IMNN) Exec Chairman Michael H. Tardugno Receives 7,169 Shares

Updated

What Happened
Michael H. Tardugno, Executive Chairman of the Board and a director of Imunon, Inc. (IMNN), was granted 7,169 shares on 2026-09-25 at a reported per-share value of $1.41, totaling about $10,108. The filing classifies the transaction as an award/grant (code A).

Key Details

  • Transaction date: 2026-09-25; reported filing date: 2026-09-28 (filed within SEC timing requirements).
  • Price per share: $1.41; total value reported: $10,108.
  • Shares acquired: 7,169 (grant/award, not an open-market purchase).
  • Shares owned after transaction: not disclosed in the provided filing excerpt.
  • Footnote: Stock was granted in lieu of cash for base salary (F1).
  • Filing timeliness: timely (filed within the required window).

Context
This was a compensation-related stock grant (cash-equivalent payment converted to shares), which is common executive compensation and not the same signal as an opportunistic open-market purchase or sale. Such awards reflect payroll/compensation practices rather than a direct market vote by the insider.

AI-written summary · check the filing